FOCUS ON MORICIZINE - A NEW PHENOTHIAZINE CLASS-I ANTIARRHYTHMIC AGENT

被引：0
|
作者：
UJHELYI, MR
KLUGER, J
CHOW, MSS
机构：
来源：
HOSPITAL FORMULARY | 1990年 / 25卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：841 / 845
页数：5
相关论文
共 50 条
  • [41] THE EFFICACY, ELECTROPHYSIOLOGIC AND ELECTROCARDIOGRAPHIC EFFECTS OF INTRAVENOUS PIRMENOL, A NEW CLASS-I ANTIARRHYTHMIC AGENT, IN PATIENTS WITH VENTRICULAR-TACHYCARDIA - COMPARISON WITH PROCAINAMIDE
    GOLD, RL
    FRUMIN, H
    HAFFAJEE, CI
    KERIN, NZ
    JARANDILLA, R
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1988, 11 (03): : 308 - 314
  • [42] THE ACUTE ELECTROPHYSIOLOGIC AND ELECTROCARDIOGRAPHIC EFFECTS OF INTRAVENOUS PIRMENOL, A NEW CLASS-I ANTIARRHYTHMIC AGENT, IN PATIENTS WITH VENTRICULAR-TACHYCARDIA - COMPARISON WITH PROCAINAMIDE
    GOLD, RI
    FRUMIN, H
    HAFFAJEE, CI
    KERIN, NZ
    CHAROS, GS
    SLOAN, K
    JARANDILLA, R
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1987, 10 (03): : 682 - 682
  • [43] ELECTROPHYSIOLOGICAL EFFECTS OF BW-A256C (NOVEL CLASS-I ANTIARRHYTHMIC AGENT) - INVITRO AND INVIVO STUDIES
    ROUET, R
    VINCENT, A
    WERQUIN, S
    LIBERSA, C
    DUPUIS, B
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1987, 1 (05) : 364 - 365
  • [44] Dofetilide: A new class III antiarrhythmic agent
    Al-Dashti, R
    Sami, M
    CANADIAN JOURNAL OF CARDIOLOGY, 2001, 17 (01) : 63 - 67
  • [45] Ibutilide: A new class III antiarrhythmic agent
    Granberry, MC
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (03) : 255 - 260
  • [46] Dofetilide, a new class III antiarrhythmic agent
    Lenz, TL
    Hilleman, DE
    PHARMACOTHERAPY, 2000, 20 (07): : 776 - 786
  • [47] Ibutilide: A new class III antiarrhythmic agent
    Cropp, JS
    Antal, EG
    Talbert, RL
    PHARMACOTHERAPY, 1997, 17 (01): : 1 - 9
  • [48] EFFECTS OF CLASS-I ANTIARRHYTHMIC AGENTS ON THE SIGNAL-AVERAGED ECG
    GOEDELMEINEN, L
    HOFMANN, M
    SCHMIDT, G
    BARTHEL, P
    BAEDEKER, W
    BLOMER, H
    HERZ, 1988, 13 (03) : 188 - 196
  • [49] ADVERSE REACTIONS DURING ACUTE AND CHRONIC CLASS-I ANTIARRHYTHMIC THERAPY
    HILLEMAN, DE
    MOHIUDDIN, SM
    GANNON, JM
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 51 (05): : 730 - 738
  • [50] EFFECT OF THE ANTIARRHYTHMIC AGENT MORICIZINE ON SURVIVAL AFTER MYOCARDIAL-INFARCTION
    ROGERS, WJ
    EPSTEIN, AE
    ARCINIEGAS, JG
    CROSSLEY, GH
    DAILEY, SM
    KAY, GN
    LITTLE, RE
    MACLEAN, WAH
    PAPAPIETRO, SE
    PLUMB, VJ
    SILBER, S
    BAKER, AR
    CARLISLE, K
    COHEN, N
    COX, M
    THOMAS, C
    LEVSON, L
    VONHAGEL, D
    WALTON, AE
    PRATT, CM
    MAHMARIAN, J
    MORRIS, G
    CAPONE, RJ
    BERGER, EE
    CHMIELEWSKI, C
    GORKIN, L
    KHAN, AH
    KORR, K
    HANDSHAW, K
    CONNOLLY, E
    FITZPATRICK, D
    CAMERON, T
    WYSE, DG
    DUFF, HJ
    MITCHELL, LB
    GILLIS, AM
    WARNICA, JW
    SHELDON, RS
    LESOWAY, NR
    KELLEN, J
    HALE, C
    INKSTER, M
    BRODSKY, M
    WOLFF, L
    ALLEN, B
    ZELMAN, R
    THOMAS, G
    CAUDILLO, G
    TAKEDA, D
    SHERWOOD, C
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (04): : 227 - 233
12345